Extended-release naltrexone versus buprenorphine-naloxone for opioid use disorder: a systematic review and meta-analysis of randomized controlled trials.
- DOI
- 10.1080/00952990.2026.2717745
- Published
- 2026 Aug 26
- Container
- The American journal of drug and alcohol abuse
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/00952990.2026.2717745,
title = {Extended-release naltrexone versus buprenorphine-naloxone for opioid use disorder: a systematic review and meta-analysis of randomized controlled trials.},
author = {Mert A and Kılıçkan D and Rodrigues Defante ML and Pereira SISD and da Silva OAFS and Jokinen J},
year = {2026},
journal = {The American journal of drug and alcohol abuse},
doi = {10.1080/00952990.2026.2717745},
url = {https://doi.org/10.1080/00952990.2026.2717745}
}RIS
TY - JOUR TI - Extended-release naltrexone versus buprenorphine-naloxone for opioid use disorder: a systematic review and meta-analysis of randomized controlled trials. AU - Mert A AU - Kılıçkan D AU - Rodrigues Defante ML AU - Pereira SISD AU - da Silva OAFS AU - Jokinen J PY - 2026 JO - The American journal of drug and alcohol abuse DO - 10.1080/00952990.2026.2717745 UR - https://doi.org/10.1080/00952990.2026.2717745 ER -
APA
A, M., D, K., ML, R. D., SISD, P., OAFS, D. S., & J, J. (2026). Extended-release naltrexone versus buprenorphine-naloxone for opioid use disorder: a systematic review and meta-analysis of randomized controlled trials.. The American journal of drug and alcohol abuse. https://doi.org/10.1080/00952990.2026.2717745
Source records
- pubmed · retrieved 2026-09-27T10:52:44.632Z
- europe-pmc · retrieved 2026-09-27T10:52:44.635Z